<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01283438</url>
  </required_header>
  <id_info>
    <org_study_id>EUBARD-CP-001</org_study_id>
    <nct_id>NCT01283438</nct_id>
  </id_info>
  <brief_title>A Prospective, Randomized, Multicenter Study to Demonstrate the Superiority of the Barricaid to Discectomy for Primary Lumbar Disc Herniation</brief_title>
  <official_title>A Prospective, Randomized, Multicenter Study to Demonstrate the Superiority of the Barricaid to Discectomy for Primary Lumbar Disc Herniation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intrinsic Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intrinsic Therapeutics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized study to demonstrate the superiority of the Barricaid® when used in conjunction
      with limited discectomy, compared to limited discectomy alone, with regard to preventing
      reherniation and the recurrence of pain or dysfunction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Barricaid is indicated for patients with radiculopathy (with or without back pain), a
      positive Straight Leg Raise (L45, L5S1) or femoral stretch test (L12, L23, L34), and a
      posterior or posterolateral herniation at one level between L1 and S1 with radiographic
      confirmation of neural compression using MRI who are found to have an annular defect (post
      discectomy) which measures between 4mm and 6mm tall and between 6mm and 10mm wide, have a
      minimum posterior disc height of 5mm, and have failed at least 6 weeks of conservative
      treatment.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 17, 2010</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Combined success of multiple clinical outcomes, including Oswestry disability index, Visual Analog Scale (VAS), and multiple radiographically confirmed measures</measure>
    <time_frame>24 months</time_frame>
    <description>To be considered a success, a patient will have achieved success in each of the following outcomes:
15 point (out of 100 point scale) improvement in Oswestry compared to pre-op
20 point (on a 100 point scale) improvement in VAS Leg (based on the primary leg complaint; if both legs have a minimum of 40/100 pre-operatively, the average leg score will be used)
Maintenance of average disc height (75% or greater of preoperative disc height) compared to pre-op
No deterioration of neurological status at the index level measured by motor function
Device integrity and lack of implant migration (radiographic, implanted patients only)
No radiographically confirmed spontaneous fusion
No radiographically or surgically confirmed reherniation at the index level (on either side)
No secondary surgical interventions at the index level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>No radiographic evidence of recurrent disc herniation</measure>
    <time_frame>24 months</time_frame>
    <description>To be considered a success, a patient will have no evidence of recurrent disc herniation at the index level at any time up to and including the 24-month follow-up. Recurrent herniation may be confirmed surgically, or radiographically as determined by an independent review (unless surgically confirmed that the suspected herniation is not a herniation, e.g. scar tissue or residual nucleus material).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale (VAS) Back Pain Improvement</measure>
    <time_frame>24 months</time_frame>
    <description>Change in back pain as measured using a Visual Analog Scale (VAS), on a scale of 0-100, with lower values representing better outcome. A subject is a success if there is at least a 20 point improvement on the VAS back at 24 months, relative to baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index (ODI) Improvement</measure>
    <time_frame>24 months</time_frame>
    <description>Change in function as measured using the Oswestry Disability Index (ODI). The ODI is scored on a scale from 0% to 100%, with higher scores indicating higher levels of disability. A subject is a success if there is at least a 15 point improvement (decrease) in the ODI at the 24 month visit relative to baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reoperation</measure>
    <time_frame>24 months</time_frame>
    <description>A subject will be deemed a success if they have not had a second operation at the index level by the 24 month visit. Rates of subject success in treatment and control will be compared at 24 months. A subject is a success if there is at least 75% of the pre-op disc height preserved at the 24 month visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale (VAS) LEG Pain Improvement</measure>
    <time_frame>24 months</time_frame>
    <description>Change in leg pain as measured using a Visual Analog Scale (VAS), on a scale of 0-100, with lower values representing better outcome. A subject is a success if there is at least a 20 point improvement on VAS leg pain in the ipsilateral leg at 24 months, relative to baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disc Height Maintenance</measure>
    <time_frame>24 months</time_frame>
    <description>A subject is a success if there is at least 75% of the pre-op disc height preserved as measured on MRI, at the 24 month visit.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">550</enrollment>
  <condition>Lumbar Disc Herniation</condition>
  <arm_group>
    <arm_group_label>Barricaid Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: Barricaid Device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard (Limited) Discectomy Only</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Barricaid</intervention_name>
    <description>CE Marked Device</description>
    <arm_group_label>Barricaid Device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard of Care</intervention_name>
    <description>Standard Limited discectomy</description>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 21 to 75 years old and skeletally mature (male or female).

          -  Patients with posterior or posterolateral disc herniations at one level between L1 and
             S1 with radiographic confirmation of neural compression using Magnetic Resonance
             Imaging (MRI).

          -  At least six (6) weeks of failed, conservative treatment prior to surgery

          -  Oswestry Disability Index (ODI) Questionnaire score of at least 40/100 at baseline.

          -  Visual Analog Scale (VAS) leg pain (one or both legs) of at least 40/100 at baseline.

          -  Psychosocially, mentally and physically able to fully comply with the clinical
             protocol and willing to adhere to follow-up schedule and requirements.

        Exclusion Criteria:

          -  Spondylolisthesis Grade II or higher (25% slip or greater).

          -  Prior surgery at the index lumbar vertebral level.

          -  Subject has scoliosis of greater than ten (10) degrees (both angular and rotational).

          -  Any metabolic bone disease.

          -  Subject has insulin-dependent diabetes mellitus.

          -  Subject has been diagnosed with active hepatitis, acquired immunodeficiency syndrome
             (AIDS), or Human immunodeficiency virus (HIV).

          -  Subject has been diagnosed with rheumatoid arthritis or other autoimmune disease.

          -  Subject has a known allergy to titanium, polyethylene or polyester materials.

          -  Any subject that cannot have a baseline MRI taken.

          -  Subject is pregnant or interested in becoming pregnant in the next three (3) years.

          -  Subject has active tuberculosis or has had tuberculosis in the past three (3) years.

          -  Subject is currently involved in another investigational study.

          -  Any contraindication for MRI or Computed tomography CT scan (e.g. claustrophobia,
             contrast allergy).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>LKH Graz</name>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Universität Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OLV Aalst</name>
      <address>
        <city>Aalst</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ZNA Middleheim / AZ Klina</name>
      <address>
        <city>Antwerp</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AZ Nikolaas</name>
      <address>
        <city>Sint Niklaas</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Lille, Hôpital Roger Salengro</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopädische Klinik und Poliklinik - Universitätsmedizin Rostock</name>
      <address>
        <city>Rostock</city>
        <state>Mecklenburg-Vorpommern</state>
        <zip>D-18055</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurochirurgische Universitätsklinik Knappschafts-Krankenhaus Bochum-Langendreer</name>
      <address>
        <city>Bochum</city>
        <state>North Rhine-Westphalia</state>
        <zip>44892</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Deggendorf</name>
      <address>
        <city>Deggendorf</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Westklinikum Hamburg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UNI Kiel</name>
      <address>
        <city>Kiel</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Bonifatius Hospital GmbH</name>
      <address>
        <city>Lingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMM Mannheim</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SLAZ Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MCH Westeinde</name>
      <address>
        <city>Den Haag</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MCH Antoniushove</name>
      <address>
        <city>Leidschendam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Isala Klinieken</name>
      <address>
        <city>Zwolle</city>
        <zip>8025AB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KSA Aarau</name>
      <address>
        <city>Aarau</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Switzerland</country>
  </location_countries>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <link>
    <url>http://www.barricaid-study.eu</url>
    <description>Patient information</description>
  </link>
  <link>
    <url>http://www.ijclinicaltrials.com/index.php/ijct/article/view/137/84</url>
    <description>Published protocol design manuscript</description>
  </link>
  <results_reference>
    <citation>Thomé C, Klassen PD, Bouma GJ, Kuršumović A, Fandino J, Barth M, Arts M, van den Brink W, Bostelmann R, Hegewald A, Heidecke V, Vajkoczy P, Fröhlich S, Wolfs J, Assaker R, Van de Kelft E, Köhler HP, Jadik S, Eustacchio S, Hes R, Martens F; Annular Closure RCT Study Group. Annular closure in lumbar microdiscectomy for prevention of reherniation: a randomized clinical trial. Spine J. 2018 Dec;18(12):2278-2287. doi: 10.1016/j.spinee.2018.05.003. Epub 2018 May 3.</citation>
    <PMID>29730458</PMID>
  </results_reference>
  <results_reference>
    <citation>Martens F, Vajkoczy P, Jadik S, Hegewald A, Stieber J, Hes R. Patients at the Highest Risk for Reherniation Following Lumbar Discectomy in a Multicenter Randomized Controlled Trial. JB JS Open Access. 2018 Apr 16;3(2):e0037. doi: 10.2106/JBJS.OA.17.00037. eCollection 2018 Jun 28.</citation>
    <PMID>30280130</PMID>
  </results_reference>
  <results_reference>
    <citation>Klassen PD, Hsu WK, Martens F, Inzana JA, van den Brink WA, Groff MW, Thomé C. Post-lumbar discectomy reoperations that are associated with poor clinical and socioeconomic outcomes can be reduced through use of a novel annular closure device: results from a 2-year randomized controlled trial. Clinicoecon Outcomes Res. 2018 Jun 26;10:349-357. doi: 10.2147/CEOR.S164129. eCollection 2018.</citation>
    <PMID>29983583</PMID>
  </results_reference>
  <results_reference>
    <citation>Ament J, Thaci B, Yang Z, Kulubya E, Hsu W, Bouma G, Kim KD. Cost-effectiveness of a Bone-anchored Annular Closure Device Versus Conventional Lumbar Discectomy in Treating Lumbar Disc Herniations. Spine (Phila Pa 1976). 2019 Jan 1;44(1):5-16. doi: 10.1097/BRS.0000000000002746.</citation>
    <PMID>29927860</PMID>
  </results_reference>
  <results_reference>
    <citation>Kuršumović A, Kienzler JC, Bouma GJ, Bostelmann R, Heggeness M, Thomé C, Miller LE, Barth M; Annular Closure RCT study group. Morphology and Clinical Relevance of Vertebral Endplate Changes Following Limited Lumbar Discectomy With or Without Bone-anchored Annular Closure. Spine (Phila Pa 1976). 2018 Oct 15;43(20):1386-1394. doi: 10.1097/BRS.0000000000002632.</citation>
    <PMID>29538243</PMID>
  </results_reference>
  <results_reference>
    <citation>Klassen PD, Bernstein DT, Köhler HP, Arts MP, Weiner B, Miller LE, Thomé C. Bone-anchored annular closure following lumbar discectomy reduces risk of complications and reoperations within 90 days of discharge. J Pain Res. 2017 Aug 26;10:2047-2055. doi: 10.2147/JPR.S144500. eCollection 2017. Erratum in: J Pain Res. 2017 Dec 06;10 :2739.</citation>
    <PMID>28894388</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 6, 2011</study_first_submitted>
  <study_first_submitted_qc>January 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2011</study_first_posted>
  <last_update_submitted>February 11, 2020</last_update_submitted>
  <last_update_submitted_qc>February 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

